U
Callitas Health Inc.
MPHMF
$0.00
$0.000.00%
D
Sell
11/9/2021Upgraded
Callitas Health Inc. (MPHMF) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
Callitas Health Inc. (MPHMF) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Callitas Health Inc. (MPHMF) was downgraded to E+ from D on 11/8/2021 due to a large decline in the solvency index and volatility index. The quick ratio declined from 0.02 to 0.
Callitas Health Inc. (MPHMF) was downgraded to E+ from D on 11/8/2021 due to a large decline in the solvency index and volatility index. The quick ratio declined from 0.02 to 0.
D
Sell
1/27/2021Upgraded
Callitas Health Inc. (MPHMF) was upgraded to D from D- on 1/27/2021 due to an increase in the volatility index.
Callitas Health Inc. (MPHMF) was upgraded to D from D- on 1/27/2021 due to an increase in the volatility index.
D
Sell
1/12/2021Downgrade
Callitas Health Inc. (MPHMF) was downgraded to D- from D on 1/12/2021 due to a substantial decline in the valuation index and volatility index.
Callitas Health Inc. (MPHMF) was downgraded to D- from D on 1/12/2021 due to a substantial decline in the valuation index and volatility index.
D
Sell
12/28/2020Upgraded
Callitas Health Inc. (MPHMF) was upgraded to D from D- on 12/28/2020 due to an increase in the volatility index.
Callitas Health Inc. (MPHMF) was upgraded to D from D- on 12/28/2020 due to an increase in the volatility index.
D
Sell
11/2/2020Downgrade
Callitas Health Inc. (MPHMF) was downgraded to D- from D on 11/2/2020 due to a significant decline in the efficiency index, solvency index and total return index. Net income declined 59.4% from -$106.4 to -$169.6, and total capital declined 2.15% from -$3.46M to -$3.53M.
Callitas Health Inc. (MPHMF) was downgraded to D- from D on 11/2/2020 due to a significant decline in the efficiency index, solvency index and total return index. Net income declined 59.4% from -$106.4 to -$169.6, and total capital declined 2.15% from -$3.46M to -$3.53M.
D
Sell
11/19/2018Downgrade
Callitas Health Inc. (MPHMF) was downgraded to D from D+ on 11/19/2018 due to a large decline in the growth index and solvency index. Operating cash flow declined 390.97% from $32.1 to -$93.4, earnings per share declined from -$0.0058 to -$0.0134, and EBIT declined 121.14% from -$194.9 to -$431.
Callitas Health Inc. (MPHMF) was downgraded to D from D+ on 11/19/2018 due to a large decline in the growth index and solvency index. Operating cash flow declined 390.97% from $32.1 to -$93.4, earnings per share declined from -$0.0058 to -$0.0134, and EBIT declined 121.14% from -$194.9 to -$431.
D
Sell
8/27/2018Upgraded
Callitas Health Inc. (MPHMF) was upgraded to D+ from D on 8/27/2018 due to an increase in the total return index.
Callitas Health Inc. (MPHMF) was upgraded to D+ from D on 8/27/2018 due to an increase in the total return index.
D
Sell
7/23/2018Downgrade
Callitas Health Inc. (MPHMF) was downgraded to D from D+ on 7/23/2018 due to a decline in the volatility index and total return index.
Callitas Health Inc. (MPHMF) was downgraded to D from D+ on 7/23/2018 due to a decline in the volatility index and total return index.
D
Sell
7/6/2018Upgraded
Callitas Health Inc. (MPHMF) was upgraded to D+ from D on 7/6/2018 due to an increase in the volatility index.
Callitas Health Inc. (MPHMF) was upgraded to D+ from D on 7/6/2018 due to an increase in the volatility index.
D
Sell
6/21/2018Downgrade
Callitas Health Inc. (MPHMF) was downgraded to D from D+ on 6/21/2018 due to a decline in the total return index and volatility index.
Callitas Health Inc. (MPHMF) was downgraded to D from D+ on 6/21/2018 due to a decline in the total return index and volatility index.
D
Sell
6/5/2018Upgraded
Callitas Health Inc. (MPHMF) was upgraded to D+ from D on 6/5/2018 due to a significant increase in the efficiency index and growth index. Earnings per share increased from -$0.145 to -$0.0058, net income increased 95.91% from -$4.53M to -$185.4, and EBIT increased 78.77% from -$918.2 to -$194.9.
Callitas Health Inc. (MPHMF) was upgraded to D+ from D on 6/5/2018 due to a significant increase in the efficiency index and growth index. Earnings per share increased from -$0.145 to -$0.0058, net income increased 95.91% from -$4.53M to -$185.4, and EBIT increased 78.77% from -$918.2 to -$194.9.
D
Sell
5/7/2018Upgraded
Callitas Health Inc. (MPHMF) was upgraded to D from D- on 5/7/2018 due to an increase in the efficiency index, total return index and valuation index.
Callitas Health Inc. (MPHMF) was upgraded to D from D- on 5/7/2018 due to an increase in the efficiency index, total return index and valuation index.
D
Sell
12/1/2017Downgrade
Callitas Health Inc. (MPHMF) was downgraded to D- from D on 12/1/2017 due to a noticeable decline in the total return index, growth index and volatility index. Operating cash flow declined 460% from -$539.3 to -$3.02M, earnings per share declined from -$0.0195 to -$0.0399, and EBIT declined 95.84% from -$430.6 to -$843.3.
Callitas Health Inc. (MPHMF) was downgraded to D- from D on 12/1/2017 due to a noticeable decline in the total return index, growth index and volatility index. Operating cash flow declined 460% from -$539.3 to -$3.02M, earnings per share declined from -$0.0195 to -$0.0399, and EBIT declined 95.84% from -$430.6 to -$843.3.
D
Sell
8/31/2017Upgraded
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 8/31/2017 due to a noticeable increase in the growth index, efficiency index and volatility index. Earnings per share increased from -$0.0043 to -$0.002, EBIT increased 38.62% from -$701.5 to -$430.6, and net income increased 38.52% from -$701.5 to -$431.3.
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 8/31/2017 due to a noticeable increase in the growth index, efficiency index and volatility index. Earnings per share increased from -$0.0043 to -$0.002, EBIT increased 38.62% from -$701.5 to -$430.6, and net income increased 38.52% from -$701.5 to -$431.3.
D
Sell
7/28/2017Upgraded
M Pharmaceutical Inc. (MPHMF) was upgraded to D- from E+ on 7/28/2017 due to an increase in the volatility index.
M Pharmaceutical Inc. (MPHMF) was upgraded to D- from E+ on 7/28/2017 due to an increase in the volatility index.
E
Sell
7/13/2017Downgrade
M Pharmaceutical Inc. (MPHMF) was downgraded to E+ from D- on 7/13/2017 due to a decline in the valuation index.
M Pharmaceutical Inc. (MPHMF) was downgraded to E+ from D- on 7/13/2017 due to a decline in the valuation index.
D
Sell
6/1/2017Downgrade
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 6/1/2017 due to a decline in the growth index and volatility index. Earnings per share declined from -$0.0012 to -$0.0043, and operating cash flow declined 37.43% from -$603 to -$828.7.
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 6/1/2017 due to a decline in the growth index and volatility index. Earnings per share declined from -$0.0012 to -$0.0043, and operating cash flow declined 37.43% from -$603 to -$828.7.
D
Sell
5/19/2017Upgraded
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 5/19/2017 due to a major increase in the growth index and total return index. Earnings per share increased from -$0.0092 to -$0.0012, and operating cash flow increased 13.54% from -$697.4 to -$603.
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 5/19/2017 due to a major increase in the growth index and total return index. Earnings per share increased from -$0.0092 to -$0.0012, and operating cash flow increased 13.54% from -$697.4 to -$603.
D
Sell
12/1/2016Downgrade
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 12/1/2016 due to a decline in the valuation index and efficiency index. Net income declined 12.82% from -$729.1 to -$822.6.
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 12/1/2016 due to a decline in the valuation index and efficiency index. Net income declined 12.82% from -$729.1 to -$822.6.
D
Sell
8/26/2016Upgraded
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 8/26/2016 due to an increase in the total return index.
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 8/26/2016 due to an increase in the total return index.
D
Sell
8/11/2016Downgrade
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 8/11/2016 due to a decline in the growth index, solvency index and efficiency index. Earnings per share declined from $0.002 to -$0.0233, net income declined 1,178.55% from $67.6 to -$729.1, and EBIT declined 120.77% from -$106.9 to -$236.
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 8/11/2016 due to a decline in the growth index, solvency index and efficiency index. Earnings per share declined from $0.002 to -$0.0233, net income declined 1,178.55% from $67.6 to -$729.1, and EBIT declined 120.77% from -$106.9 to -$236.
D
Sell
8/5/2016Upgraded
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 8/5/2016 due to an increase in the volatility index and total return index.
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 8/5/2016 due to an increase in the volatility index and total return index.
D
Sell
5/24/2016Downgrade
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 5/24/2016 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 100% from $64.6 to $0, and the quick ratio declined from 0 to 0.
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 5/24/2016 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 100% from $64.6 to $0, and the quick ratio declined from 0 to 0.
D
Sell
5/2/2016Upgraded
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 5/2/2016 due to a significant increase in the efficiency index.
M Pharmaceutical Inc. (MPHMF) was upgraded to D from D- on 5/2/2016 due to a significant increase in the efficiency index.
D
Sell
3/11/2016Downgrade
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index and total return index.
M Pharmaceutical Inc. (MPHMF) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index and total return index.
D
Sell
1/12/2016Downgrade
M Pharmaceutical Inc. (MPHMF) was downgraded to D from D+ on 1/12/2016 due to a decline in the total return index.
M Pharmaceutical Inc. (MPHMF) was downgraded to D from D+ on 1/12/2016 due to a decline in the total return index.
D
Sell
12/28/2015Upgraded
M Pharmaceutical Inc. (MPHMF) was upgraded to D+ from D on 12/28/2015 due to a large increase in the growth index, valuation index and total return index. Operating cash flow increased 24% from -$157.5 to -$195.3.
M Pharmaceutical Inc. (MPHMF) was upgraded to D+ from D on 12/28/2015 due to a large increase in the growth index, valuation index and total return index. Operating cash flow increased 24% from -$157.5 to -$195.3.
D
Sell
5/29/2015Downgrade
M Pharmaceutical Inc. (PTWHF) was downgraded to D from C- on 5/29/2015 due to a significant decline in the efficiency index, valuation index and growth index. Total capital declined 545.08% from -$118 to $525.2, net income declined 261.09% from $251.1 to -$404.5, and earnings per share declined from $0.0305 to -$0.0035.
M Pharmaceutical Inc. (PTWHF) was downgraded to D from C- on 5/29/2015 due to a significant decline in the efficiency index, valuation index and growth index. Total capital declined 545.08% from -$118 to $525.2, net income declined 261.09% from $251.1 to -$404.5, and earnings per share declined from $0.0305 to -$0.0035.
C
Hold
2/13/2015Upgraded
Callitas Health Inc. (MPHMF) was upgraded to C- from U on 02/13/2015.
Callitas Health Inc. (MPHMF) was upgraded to C- from U on 02/13/2015.
D
Sell
1/2/2015Downgrade
M Pharmaceutical Inc. (PTWHF) was downgraded to D+ from C- on 1/2/2015 due to a decline in the volatility index.
M Pharmaceutical Inc. (PTWHF) was downgraded to D+ from C- on 1/2/2015 due to a decline in the volatility index.
C
Hold
11/26/2014Upgraded
First Sahara Energy Inc. (PTWHF) was upgraded to C- from D on 11/26/2014 due to a significant increase in the efficiency index, growth index and solvency index. Debt to equity declined from -1.86 to -0.34, and net income increased 32.93% from -$164.9 to -$219.2.
First Sahara Energy Inc. (PTWHF) was upgraded to C- from D on 11/26/2014 due to a significant increase in the efficiency index, growth index and solvency index. Debt to equity declined from -1.86 to -0.34, and net income increased 32.93% from -$164.9 to -$219.2.
D
Sell
8/27/2014Downgrade
First Sahara Energy Inc. (PTWHF) was downgraded to D from C on 8/27/2014 due to a significant decline in the efficiency index, growth index and total return index. Total capital declined 130.59% from -$558.6 to $170.9, earnings per share declined from -$0.0079 to -$0.0056, and net income declined 12.1% from -$187.6 to -$164.9.
First Sahara Energy Inc. (PTWHF) was downgraded to D from C on 8/27/2014 due to a significant decline in the efficiency index, growth index and total return index. Total capital declined 130.59% from -$558.6 to $170.9, earnings per share declined from -$0.0079 to -$0.0056, and net income declined 12.1% from -$187.6 to -$164.9.
C
Hold
8/15/2014Upgraded
First Sahara Energy Inc. (PTWHF) was upgraded to C from D on 8/15/2014 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 130.49% from -$58.7 to -$135.3.
First Sahara Energy Inc. (PTWHF) was upgraded to C from D on 8/15/2014 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 130.49% from -$58.7 to -$135.3.
D
Sell
5/1/2014Downgrade
First Sahara Energy Inc. (PTWHF) was downgraded to D from D+ on 5/1/2014 due to a large decline in the efficiency index, solvency index and growth index. Debt to equity increased from 0.01 to 0.05, operating cash flow declined 87.47% from -$468.5 to -$58.7, and total capital declined 66.42% from $15.39M to $5.17M.
First Sahara Energy Inc. (PTWHF) was downgraded to D from D+ on 5/1/2014 due to a large decline in the efficiency index, solvency index and growth index. Debt to equity increased from 0.01 to 0.05, operating cash flow declined 87.47% from -$468.5 to -$58.7, and total capital declined 66.42% from $15.39M to $5.17M.
D
Sell
2/28/2014Upgraded
First Sahara Energy Inc. (PTWHF) was upgraded to D+ from D on 2/28/2014 due to an increase in total return, efficiency and solvency.
First Sahara Energy Inc. (PTWHF) was upgraded to D+ from D on 2/28/2014 due to an increase in total return, efficiency and solvency.
OTC PK
01/28/2025 12:25PM Eastern
Quotes delayed
